Iron status and burden of anemia in children with recessive dystrophic epidermolysis bullosa
Pediatric Dermatology · 2023
DOI: 10.1111/pde.15239 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Dermatology, 2023. Verfasst von Cristina Tarango und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center and the University of Cincinnati College o…. Hauptthemen laut MEDLINE: Epidermolysis Bullosa Dystrophica, Anemia, Anemia, Iron-Deficiency, Iron Deficiencies. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background and Objectives To describe the prevalence, severity, and management of anemia in a cohort of children with recessive dystrophic epidermolysis bullosa (RDEB) and to highlight the use of soluble transferrin receptor (sTfR) to diagnose iron deficiency in this chronic inflammatory state.
Methods
We studied a cohort of 114 patients with RDEB followed at a pediatric hospital‐based Epidermolysis Bullosa Center from 2010 to 2020; data were prospectively tracked in a comprehensive clinical database that captured all visits, laboratory tests, iron infusions, and transfusions. The primary outcome was occurrence of anemia, which was assessed by age and sex, with and without transfusion support. Secondary outcomes included iron status using a combination of ferritin and sTfR levels, the cumulative incidence of parenteral iron therapy and transfusions, and survival.
Results
In RDEB, anemia begins in the first year of life and becomes more frequent and severe with age. The prevalence of iron deficiency anemia (IDA) estimated by ferritin was 33.6% (37/110), but the sTfR/log 10 ‐ferritin ratio indicated a 1.5‐fold higher true prevalence of IDA of 50.6% (41/81). 53.5% (61/114) received parenteral iron infusions, transfusions, or both. Higher ferritin was associated with earlier mortality.
Conclusions
Individuals with RDEB have a high burden of anemia (IDA and anemia of inflammation) that requires frequent medical interventions. The sTfR/log 10 ‐ferritin ratio improves the detection of iron deficiency in the context of inflammation and guides therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
- Division of Dermatology, Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
ORCID-Profile: Cristina Tarango, Bret Augsburger
Zitieren
APA
Tarango, C., Quinn, C. T., Augsburger, B., & Lucky, A. W. (2023). Iron status and burden of anemia in children with recessive dystrophic epidermolysis bullosa. Pediatric Dermatology. https://doi.org/10.1111/pde.15239
Vancouver
Tarango C, Quinn CT, Augsburger B, Lucky AW. Iron status and burden of anemia in children with recessive dystrophic epidermolysis bullosa. Pediatric Dermatology. 2023. doi:10.1111/pde.15239
BibTeX
@article{Tarango2023,
author = {Tarango, Cristina and Quinn, Charles T and Augsburger, Bret and Lucky, Anne W},
title = {Iron status and burden of anemia in children with recessive dystrophic epidermolysis bullosa},
journal = {Pediatric Dermatology},
year = {2023},
doi = {10.1111/pde.15239}
}
EUVIMED